Created by Carrie Murray, the new series explores what it means to amplify voices, navigate darkness, and use story as a catalyst for social change LOS ANGELES, CA / ACCESS Newswire / July 31, 2025 / In a time of uncertainty, storytelling becomes a lifeline. It connects us to not only the truth, but to […]

NEW YORK CITY, NY / ACCESS Newswire / July 31, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Charter Communications, Inc. ("Charter" or "the Company") (NASDAQ:CHTR). Investors who purchased Charter securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/CHTR.

NEW YORK CITY, NY / ACCESS Newswire / July 31, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Novo Nordisk A/S ("Novo Nordisk" or "the Company") (NYSE:NVO). Investors who purchased Novo Nordisk securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s

NEW YORK, NY / ACCESS Newswire / July 31, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Barnes & Noble Education, Inc. ("Barnes & Noble" or "the Company") (NYSE:BNED). Investors who purchased Barnes & Noble securities are encouraged to obtain additional information and assist the investigation by

NEW YORK CITY, NY / ACCESS Newswire / July 31, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nutex Health, Inc. ("Nutex" or "the Company") (NASDAQ:NUTX). Investors who purchased Nutex securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/NUTX.

NEW YORK, NY / ACCESS Newswire / July 31, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Equinix, Inc. ("Equinix" or "the Company") (NASDAQ:EQIX). Investors who purchased Equinix securities prior to May 3, 2019, and continue to hold to the present, are encouraged to obtain additional information

NEW YORK, NY / ACCESS Newswire / July 31, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dow Inc. ("Dow" or "the Company") (NYSE:DOW). Investors who purchased Dow securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/DOW. Investigation Details

NEW YORK, NY / ACCESS Newswire / July 31, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Telix Pharmaceuticals Limited ("Telix" or "the Company") (NASDAQ:TLX). Investors who purchased Telix securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/TLX. Investigation

NEW YORK CITY, NY / ACCESS Newswire / July 31, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PACS Group, Inc. ("PACS Group" or "the Company") (NYSE:PACS). Investors who purchased PACS Group securities prior to April 11, 2024, and continue to hold to the present, are encouraged

NEW YORK, NY / ACCESS Newswire / July 31, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC). Investors who purchased Acadia Healthcare securities prior to February 28, 2020, and continue to hold to the present, are encouraged